Comparison of putative dopamine receptors in blood vessels and the central nervous system.
D000547:Amantadine / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001060:Aporphines / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D004285:Dogs; D004298:Dopamine / Q000378:metabolism* / Q000494:pharmacology; D018492:Dopamine Antagonists; D004357:Drug Synergism; D006220:Haloperidol / Q000494:pharmacology; D007668:Kidney / Q000098:blood supply; D010891:Piribedil / Q000494:pharmacology; D011955:Receptors, Drug; D013881:Thioridazine / Q000494:pharmacology; D014268:Trifluoperazine / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D001060:Aporphines; D018492:Dopamine Antagonists; D011955:Receptors, Drug; D014268:Trifluoperazine; D000547:Amantadine; D000661:Amphetamine; D010891:Piribedil; D006220:Haloperidol; D013881:Thioridazine; D002746:Chlorpromazine; D004298:Dopamine; D014439:Tyramine